Re: Lung cancer mortality from radon versus mortality from other<plus>Radon...

["John Jacobus" <jenday1@EMAIL.MSN.COM>]

Howard,

I am glad you and members of the audience, including several Noble Prize

winners were convinced.  Did the members of the audience have the same

well-founded background in epidemiology that you do?  I am sure you are

aware of the story of N rays that were discovered at the beginning of this

century in France.  If I remember correctly, the discover was awared a medal

by the French Academy even after the existance of N rays were disproven.

There is a difference between science and wishful thinking.  The question is

does the study satisfy other epidemiologist.  Apparently, there is a bit of

dissent over Dr. Cohen's conclusions.



Also, what dose LNT have to do with medicine?  Your comments regarding

radiation to boost the immune systems of AIDS-infected patients is

interesting.  Why do you not put in a grant for the work?  However, your

comment about radiation to prevent restenosis makes me wonder how much you

know about the subject of radiation in medicine.



-- John



John Jacobus, MS

Certified Health Physicist

3050 Traymore Lane

Bowie, MD 20715-2024

jenday1@email.msn.com (H)

------------------------------

Howard Long worte:

. . .

Professor Mossman,

"Cohen - must convince the scientific community that everyone else

is wrong [who accepts LNT]." ?  Not so. He and others have already.



At 2 presentations I witnessed, Doctors for Disaster Preparedness meetings,

Cohen did convince all present (including several Nobel Prize winners) that

his data does refute LNT. Furthermore, statisticians have witnessed

on radsafe that LNT is implausible, given Cohen's data.



Furthermore, LNT for chemicals is incompatible with the daily practice

of any physician, as we carefully dose poisons (most pharmaceuticals having

LD 50s, like ionizing radiation). Prescribing radiation UNDER THRESHHOLD

DOSE

should soon be boosting immunity to infections (as in AIDS), speeding wound

healing, and stimulating resistance to cancer. Now, it minimizes restenosis

in

coronary stents.  Would you prohibit - or delay -  individual choice of

these dose-dependent

benefits?

. . .





************************************************************************

You are currently subscribed to the Radsafe mailing list. To unsubscribe,

send an e-mail to Majordomo@list.vanderbilt.edu  Put the text "unsubscribe

radsafe" (no quote marks) in the body of the e-mail, with no subject line. You can view the Radsafe archives at http://www.vanderbilt.edu/radsafe/